99 related articles for article (PubMed ID: 31307202)
21. Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencing.
Zheng Y; Long J; Wu L; Zhang H; Li L; Zheng Y; Wang A; Lin J; Yang X; Sang X; Hu K; Pan J; Zhao H
Oncotarget; 2017 Sep; 8(36):60358-60367. PubMed ID: 28947976
[TBL] [Abstract][Full Text] [Related]
22. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
[TBL] [Abstract][Full Text] [Related]
23. Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma.
Xu W; Rao Q; An Y; Li M; Zhang Z
PLoS One; 2018; 13(8):e0202763. PubMed ID: 30138346
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
25. Microarray‑based bioinformatics analysis of the prospective target gene network of key miRNAs influenced by long non‑coding RNA PVT1 in HCC.
Zhang Y; Mo WJ; Wang X; Zhang TT; Qin Y; Wang HL; Chen G; Wei DM; Dang YW
Oncol Rep; 2018 Jul; 40(1):226-240. PubMed ID: 29749550
[TBL] [Abstract][Full Text] [Related]
26. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
27. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
[TBL] [Abstract][Full Text] [Related]
28. The underlying pathophysiology association between the Type 2-diabetic and hepatocellular carcinoma.
Wei H; Wang J; Li W; Ma R; Xu Z; Luo Z; Lu Y; Zhang X; Long X; Pu J; Tang Q
J Cell Physiol; 2019 Jul; 234(7):10835-10841. PubMed ID: 30585632
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
[TBL] [Abstract][Full Text] [Related]
30. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.
Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N
Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267
[TBL] [Abstract][Full Text] [Related]
31. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY
Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053
[TBL] [Abstract][Full Text] [Related]
33. Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis.
Zhou RS; Wang XW; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
Biomed Res Int; 2019; 2019():3065818. PubMed ID: 31236404
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
35. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC).
Xu W; Huang H; Yu L; Cao L
Med Oncol; 2015 Apr; 32(4):96. PubMed ID: 25731616
[TBL] [Abstract][Full Text] [Related]
37. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
[TBL] [Abstract][Full Text] [Related]
38. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
[TBL] [Abstract][Full Text] [Related]
40. A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion.
Mo M; Liu S; Ma X; Tan C; Wei L; Sheng Y; Song Y; Zeng X; Huang D; Qiu X
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2027-2038. PubMed ID: 31243545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]